Elevated Capital Advisors, LLC Danaher Corp Transaction History

Elevated Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$241.42 - $282.29 $913,291 - $1.07 Million	-3,783 Closed	0 $0
Q3 2022 Oct 06, 2022	SELL	$247.06 - $1507.4 $632,720 - $3.86 Million	-2,561 Reduced 40.37%	3,783 $977,000
Q1 2022 Apr 20, 2022	SELL	$257.27 - $315.76 $2,315 - $2,841	-9 Reduced 0.14%	6,344 $1.86 Million
Q3 2021 Oct 07, 2021	BUY	$272.21 - $332.43 $467,384 - $570,782	1,717 Added 37.04%	6,353 $1.93 Million
Q1 2021 Apr 21, 2021	BUY	$212.38 - $245.9 $134,861 - $156,146	635 Added 15.87%	4,636 $1.12 Million
Q4 2020 Feb 25, 2021	BUY	$212.5 - $245.46 $122,825 - $141,875	578 Added 16.89%	4,001 $889,000
Q3 2020 Nov 27, 2020	SELL	$177.16 - $215.33 $62,360 - $75,796	-352 Reduced 9.32%	3,423 $773,000
Q2 2020 Sep 11, 2020	BUY	$128.7 - $176.83 $279,021 - $383,367	2,168 Added 134.91%	3,775 $793,000
Q4 2019 Feb 06, 2020	SELL	$133.47 - $153.48 $434,578 - $499,730	-3,256 Reduced 66.95%	1,607 $247,000
Q1 2019 Apr 16, 2020	BUY	$97.62 - $132.29 $474,726 - $643,326	4,863 New	4,863 $743,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Elevated Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Elevated Capital Advisors, LLC with notifications on news.